NuCana (NCNA) Projected to Post Earnings on Wednesday

NuCana (NASDAQ:NCNA) is projected to release its earnings data before the market opens on Wednesday, March 19th. Analysts expect NuCana to post earnings of ($2.43) per share for the quarter.

NuCana Stock Performance

NASDAQ NCNA opened at $0.76 on Monday. NuCana has a 52-week low of $0.75 and a 52-week high of $10.79. The company has a market capitalization of $2.01 million, a P/E ratio of -0.07 and a beta of 0.89. The company has a fifty day moving average of $1.00 and a 200-day moving average of $1.64.

About NuCana

NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of medicines to treat patients with cancer. It applies its ProTide technology to transform prescribed chemotherapy agents and nucleoside analogs into medicines. The company, through its technology, is developing ProTides medicines to overcome the limitations of nucleoside analogs and generate much higher concentrations of anti-cancer metabolites in cancer cells.